Management of Hot Flushes in Breast Cancer Survivors: Comparison Between Stellate Ganglion Block and Pregabalin

Pain Medicine (United States)

Volumn 15, Issue 3, 2014, Pages 410-417

  Othman, Ahmed H ^a   Zaky, Amen H ^a  

^a ASSIUT UNIVERSITY   (Egypt)

Author keywords

Breast Cancer; Hot Flushes; Pregabalin; Stellate Ganglion Block

Indexed keywords

BUPIVACAINE; FENTANYL; MIDAZOLAM; POVIDONE IODINE; PREGABALIN;

ADULT; ARTICLE; BREAST CANCER; CANCER SURVIVOR; CLINICAL ARTICLE; COMPARATIVE STUDY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HOARSENESS; HOT FLUSH; HUMAN; MIDDLE AGED; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAFETY; STATISTICAL ANALYSIS; STELLATE GANGLION BLOCK; THERAPY EFFECT; TREATMENT OUTCOME;

BREAST CANCER; HOT FLUSHES; PREGABALIN; STELLATE GANGLION BLOCK;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HOT FLASHES; HUMANS; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; STELLATE GANGLION; SURVIVORS; TREATMENT OUTCOME;

EID: 84895534445     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12331     Document Type: Article

References (29)

1. Carpenter JS, Andrykowski MA. Menopausal symptoms in breast cancer survivors. Oncol Nurs Forum 1999;26:1311-1317.
2. Couzi R, Helzlsouer K, Fetting J. Prevelance of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 1995;13:2737-2744.
3. Finck G, Barton D, Loprinzi C, etal. Definitions of hot flushes in breast cancer survivors. J Pain Symptom Manage 1998;16:327-333.
4. Carpenter J, Johnson D, Wagner L, Andrykowski M. Hot flushes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum 2002;29:E16-25.
5. Goldberg RM, Loprinzi CL, O'Fallon JR, etal. Transdermal clonidine for ameliorating tamoxifen induced hot flushes. J Clin Oncol 1994;12:155-158.
6. Pandya KJ, Raubertas RF, Flynn PJ, etal. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flushes: A University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med 2000;132:788-793.
7. Sloan JA, Loprinzi CL, Novotny PJ, etal. Methodologic lessons learned from hot flush studies. J Clin Oncol 2001;19:4280-4290.
8. Barton DL, LaVasseur BI, Sloan JA, etal. Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9. J Clin Oncol 2010;28:3278-3283.
9. Loprinzi CL, Kugler JW, Sloan JA, etal. Venlafaxine in management of hot flushes in survivors of breast cancer: A randomised controlled trial. Lancet 2000;356:2059-2063.
10. Loprinzi CL, Sloan J, Stearns V, etal. Newer antidepressants and gabapentin for hot flushes: An individual patient pooled analysis. J Clin Oncol 2009;27:2831-2837.
11. Loprinzi CL, Sloan JA, Perez EA, etal. Phase III evaluation of fluoxetine for treatment of hot flushes. J Clin Oncol 2002;20:1578-1583.
12. Speroff L, Gass M, Constantine G, Olivier S. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: A randomized controlled trial. Obstet Gynecol 2008;111:77-87.
13. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flushes: A randomized controlled trial. JAMA 2003;289:2827-2834.
14. Stearns V, Slack R, Greep N, etal. Paroxetine is an effective treatment for hot flushes: Results from a prospective randomized clinical trial. J Clin Oncol 2005;23:6919-6930.
15. Guttuso TJ Jr. Gabapentin's effects on hot flushes and hypothermia. Neurology 2000;54:2161-2163.
16. Loprinzi CL, Qin R, Balcueva EP, etal. Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flushes, N07C1. J Clin Oncol 2010;28:641-647.
17. Pandya KJ, Morrow GR, Roscoe JA, etal. Gabapentin for hot flushes in 420 women with breast cancer: A randomised double-blind placebo-controlled trial. Lancet 2005;366:818-824.
18. Loprinzi C, Barton D, Rhodes D. Management of hot flushes in breast-cancer survivors. Lancet Oncol 2001;2:199-204.
19. Lipov EG, Joshi JR, Sanders S, Slavin KV. A unifying theory linking the prolonged efficacy of the stellate ganglion block for the treatment of chronic regional pain syndrome (CRPS), hot flushes, and posttraumatic stress disorder (PTSD). Med Hypotheses 2009;72:657-661.
20. Lipov EG, Lipov S, Joshi JR, etal. Stellate ganglion block may relieve hot flushes by interrupting the sympathetic nervous system. Med Hypotheses 2007;69:758-763.
21. Tourney W. Occurrance and management of reflex sympathetic dystropy (causalgia of the extremities). J Bone Joint Surg 1948;30:883-907.
22. Lipov E, Lipov S, Stark JT. Stellate ganglion blockade provides relief from menopausal hot flushes: A case report series. J Womens Health 2005;14:737-741.
23. Lipov EG, Joshi JR, Sanders S, etal. Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: A pilot study. Lancet Oncol 2008;9:523-532.
24. Lipov EG, Joshi JR, Xie H, Slavin KV. Updated findings on the effects of stellate-ganglion block on hot flushes and night awakenings. Lancet Oncol 2008;9:819-820.
25. Haest K, Kumar A, Leunen K, etal. Does the stellate ganglion block reduce severe hot flushes and sleep disturbances in breast cancer patients? Cancer Res 2009;69(suppl 24):809.
26. Elias M. Cervical sympathetic and stellate ganglion blocks. Pain Physician 2000;3:294-304.
27. Breivik H, Cousins M, Lofstrom JB. Sympathetic neural blockade of upper and lower extremity. In: Cousins MJ, Bridenbaugh PO, eds. Neural Blockade in Clinical Anesthesia and Management of Pain, 3rd edition. Philadelphia, PA: Lippincott-Raven; 1998:411-447.
28. Wulf H, Maier C. Complications and side effects of stellate ganglion blockade. Results of a questionnaire survey. Anaesthesist 1992;41:146-151.
29. Pachman DR, Barton D, Carns PE, etal. Pilot evaluation of a stellate ganglion block for the treatment of hot flushes. Support Care Cancer 2011;19:941-947.